Concentra price target raised to $26 from $25 at BofA

BofA raised the firm’s price target on Concentra (CON) to $26 from $25 and keeps a Buy rating on the shares. Q4 results were in line the company’s pre-announcement and Concentra reaffirmed its 2025 guidance provided in conjunction with the Nova acquisition in late January, the analyst noted. The firm is applying a higher multiple to its estimates given higher confidence in estimates as well as Concentra’s unique payor mix, mid-single digits organic growth, potential upside from capital deployment, the analyst tells investors.